Pharmagen ApS — Credit Rating and Financial Key Figures

CVR number: 36687193
Grusbakken 2 D, 2820 Gentofte

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit373.32337.177.86-10.06-14.20
EBIT373.32337.177.86-10.06-14.20
Other financial income127.40-0.0028.11
Other financial expenses- 275.46-8.02-1.95-2.74-5.10
Net income from associates (fin.)-4.45
Pre-tax profit97.86456.551.4615.31-19.30
Income taxes-21.91-73.23- 243.53
Net earnings75.95383.32- 242.0715.31-19.30

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Non-current loans receivable336.59785.95785.95785.95785.95
Long term receivables total336.59785.95785.95785.95785.95
Inventories total
Current trade debtors35.88
Current other receivables48.1918.6814.00
Current deferred tax assets316.77300.54
Short term receivables total316.77336.4148.1918.6814.00
Cash and bank deposits230.25104.39131.69147.32132.70
Cash and cash equivalents230.25104.39131.69147.32132.70
Balance sheet total (assets)883.611 226.75965.82951.95932.64

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Retained earnings- 574.37- 498.42- 115.10- 357.17- 341.86
Profit of the financial year75.95383.32- 242.0715.31-19.30
Shareholders equity total- 448.42-65.10- 307.17- 291.86- 311.16
Non-current liabilities total
Current trade creditors10.009.238.508.508.50
Current owed to participating1 212.211 264.491 264.491 235.311 235.31
Short-term deferred tax liabilities38.56
Other non-interest bearing current liabilities71.2518.130.000.00
Current liabilities total1 332.031 291.851 272.991 243.811 243.81
Balance sheet total (liabilities)883.611 226.75965.82951.95932.64
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.